Trials / Not Yet Recruiting
Not Yet RecruitingNCT06412042
Probiotic in Infant Growth, Allergy and Immunity Study
Prospective, Placebo-Controlled, Randomized Double-Blind Clinical Study on the Intervention of Animal-Derived Probiotic in Infant Growth and Development, Allergy Incidence, and Immune Function
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Wecare Probiotics Co., Ltd. · Industry
- Sex
- All
- Age
- 36 Months
- Healthy volunteers
- Accepted
Summary
To evaluate the intervention effects of Bifidobacterium animalis subsp. lactis strain BLa80 in promoting growth and development (including gut microbiota and physical growth and development) of healthy infants and young children across different age groups, enhancing immune function, improving allergy incidence, and analyzing the safety of BLa80 in relation to infant growth and development, allergy incidence, and gut microbiota.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic BLa80 | Collect baby fecal samples, test for 16S rRNA, and analyze changes in the gut microbiota before and after supplementation. |
| OTHER | Placebo Maltodextrin | Collect baby fecal samples, test for 16S rRNA, and analyze changes in the gut microbiota before and after supplementation. |
Timeline
- Start date
- 2024-06-15
- Primary completion
- 2024-09-15
- Completion
- 2024-09-25
- First posted
- 2024-05-14
- Last updated
- 2024-05-14
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT06412042. Inclusion in this directory is not an endorsement.